An eye-tracking device could help ventilator patients communicate with doctors even though they are unable to speak, a Johns Hopkins University study of 12 patients found.
Abbott once again said at the TCT conference that its drug-eluting bioresorbable Absorb BVS is comparable, or noninferior, to its standard drug-eluting Xience stent, as it seeks FDA approval next year, which would make it the first company to sell a fully bioresorbable stent in the U.S.
HeartWare was down about 30% after announcing that it might not be able to resume a European trial of its MVAD implantable heart pump next month, a month after the company put the study on hold due to manufacturing and software issues with the device.
DNA testing outfit DNA Diagnostics is selling out to European healthcare investor GHO Capital for €104 million ($118 million), allowing GHO to cash in on the genetic testing market and expand its international footprint while increasing DDC's global reach.
California-based Uptake Medical reports its targeted vapor therapy system used in a "first-ever" human regional lung cancer tumor ablation procedure resulted in a 90% successful removal of the tumor.
Medtronic announced promising results from the first-in-human implants of its investigational drug-filled stent at the TCT conference in San Francisco.
China FDA has issued four guidance documents to improve its oversight of the country's device industry.
The ongoing Transcatheter Cardiovascular Therapeutics conference in San Francisco couldn't be any more timely, with bigwigs Abbott, Edwards, and Medtronic dropping more than $1 billion on the burgeoning transcatheter mitral valve repair/replacement market in recent months.
Roche won a contract in the Netherlands to provide its HPV test for primary screening of cervical cancer through the country's national cervical cancer screening program, a milestone for the company more than a year after its scored FDA approval for its diagnostic for frontline HPV testing.
Spinal device specialist NuVasive got an FDA nod for its spinal cord surgical product, building out its portfolio as the company fights for dominance in a competitive market.
Baxter's suspension of a randomized clinical trial of adjustable ultrafiltration to treat heart failure has proven unpopular with study investigators and subject matter experts, who described the move as premature and unilateral in the Journal of the American College of Cardiology.
Doctors at Massachusetts General Hospital are hoping electrode implants can deliver deep brain stimulation that could eventually help treat an array of psychiatric illnesses ranging from post-traumatic stress disorder to schizophrenia.
Medtronic announced the first implants of its deep brain stimulation system in conjunction with its bioabsorbable antibacterial envelope to prevent surgical site infections. The milestone occurred at the Barrow Neurological Institute in Phoenix. Medtronic also said it plans to soon make the technology available for use with its neurostimulators for chronic pain and bladder/bowel control disorders.
Onkos Surgical has secured a Series A financing and partnered with MicroPort Orthopedics. The financial details were undisclosed in the company's announcement, but an SEC filing reveals that Onkos recently secured the first $6.1 million of a financing that's expected to total $15.3 million.
As 3-D printing gains traction in the surgical realm, 3-D printing company Stratasys is touting the benefits of the technology in a success story of a procedure carried out with its devices.
Procyrion is developing what it says is the first catheter-deployed micropump for the heart and has nabbed a $10 million Series B round to back clinical development.
Zoll has completed the rollout of its ResQCPR System to perform cardiopulmonary resuscitation (CPR) on cardiac arrest patients. Seven months after the ResQCPR's FDA approval, it is now available nationwide, Zoll announced.
FIFA will discuss the use of wearable electronic performance and tracking systems at its upcoming round of meetings beginning Nov. 16.
BioMérieux's BioFire Diagnostics got an FDA OK for its rapid meningitis and encephalitis test, a feather in the company's cap as it diversifies its portfolio and ramps up business in an increasingly competitive market.
The Internet of Things revolution for medical devices is here. And, not too surprisingly, it's being led by Amazon--yet another big-name tech contender working to get in on the evolution of healthcare via technology. Google, along with other big IT names such as IBM, Salesforce and Siemens, are all in the midst of trying to secure a profitable spot in next-gen healthcare.